NAUT: SEC Form 8-K filed by Nautilus Biotechnology Inc.
Stocks in this Quantisnow insightIndustrials
Full content unavailable. See the original source below.
Historical context for NAUT
Across the 19 sessions after earlier NAUT headlines, the stock closed higher 9 times and lower 8 times, with a median move of 5.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | NAUT | SPY |
|---|---|---|---|
| Oct 15, 2026 | Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026 | +0.0% | +0.3% |
| Sep 29, 2026 | Roth Capital initiated coverage on Nautilus Biotechnology with a new price target | +23.0% | -0.2% |
| Sep 9, 2026 | Leerink Partners initiated coverage on Nautilus Biotechnology with a new price target | +20.7% | -0.5% |
| Sep 4, 2026 | Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms | -1.6% | -0.4% |
| Jul 28, 2026 | Nautilus Biotechnology Reports Second Quarter 2026 Financial Results | -27.7% | +0.2% |
| Jul 8, 2026 | Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 | +5.3% | -0.3% |
Quantisnow market dataNASDAQ
NAUT
Nautilus Biotechnology Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Listed since
- 2020
Get push alerts for NAUT
Full NAUT profile on Quantisnow Follow NAUT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time